Ann Surg23 Dec 2023
Robotic pancreatoduodenectomy (RPD) was compared to laparoscopic pancreatoduodenectomy (LPD) in terms of operative and oncologic outcomes in a multicenter study involving 2,255 patients. After propensity score matching, 1,006 patients were included in each group. RPD had shorter operative time, lower blood transfusion and conversion rates,…
Ann Surg23 Dec 2023
Researchers analyzed nationwide outcomes after pancreatoduodenectomy in patients at very high risk for postoperative pancreatic fistula (POPF). The study found a 4.1% in-hospital mortality rate and observed major morbidity in 45.9% of patients. POPF occurred in 30% of patients, leading to increased major morbidity and…
Ann Surg23 Dec 2023
A retrospective multicenter study aimed to develop prediction models for major morbidity and endocrine dysfunction following central pancreatectomy (CP). The study included 838 patients from 51 centers in 19 countries. The risk model for major morbidity identified male sex, age, BMI, and ASA score ≥3…
HPB (Oxford)23 Dec 2023
Robotic pancreaticoduodenectomy (RPD) is a safe and effective procedure, although it often takes longer than open pancreaticoduodenectomy (OPD). A study analyzed elective, low-risk RPD and OPD cases to determine the operative time threshold (OTT) for safety in RPD patients. The OTT was identified as 7.7…
Ann Surg Oncol22 Dec 2023
A recent study provides a comprehensive step-by-step overview of mesopancreas dissection during robotic pancreatoduodenectomy (PD) and its three levels based on tumor type. Surgeons interested in the robotic approach for PD should be familiar with these levels to ensure safe and successful dissections. The study…
BMC Surg22 Dec 2023
The study aimed to assess the prognostic relevance of splenic vessel involvement in distal pancreatic adenocarcinoma. The researchers identified 149 patients who underwent surgery, with 46.3% showing splenic vascular involvement. Among them, 14.8% had a pathologic tumor thrombosis of the splenic vein. The presence of…
HPB (Oxford)22 Dec 2023
Researchers investigated the misdiagnosis of suspected cancer among patients undergoing pancreatoduodenectomy (PD) over a 30-year period. They found that diagnostic errors resulted in PD being mistakenly performed for benign disease. Of the 1,812 patients who underwent PD for suspected malignancy, 97 (5.2%) were ultimately diagnosed…
HPB (Oxford)22 Dec 2023
According to a systematic review and meta-analysis, researchers found that lymph node dissection (LND) did not significantly impact overall survival, disease-free survival, or risk of major complications in patients with intrahepatic cholangiocarcinoma (ICC). However, for clinically node-negative patients, LND was associated with improved overall survival…
BMC Surg21 Dec 2023
A retrospective multicenter analysis involving 503 patients who underwent pancreaticoduodenectomy revealed that perioperative oral care management significantly reduces the incidence of organ/space surgical site infections. Patients who received oral care management had a lower rate of complications compared to those who did not. The study…
BMC Surg21 Dec 2023
The study aimed to determine the textbook outcome in distal pancreatectomy by analyzing a multicenter database. The specific definition of textbook outcome included factors such as hospital stay, complications, mortality, readmission, and absence of pancreatic fistula. Among the 450 patients included, 58.2% achieved textbook outcomes.…